Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

You may be eligible if

• At least 12 years of age
• Diagnosis of cystic fibrosis with mild to moderate pulmonary impairment
• Must be receiving ongoing chronic treatment with TOBI (inhaled tobramycin) OR not receiving ongoing chronic treatment with TOBI and no use of TOBI or other inhaled antibiotic within 4 weeks prior to study drug administration·
• Other specific diagnostic indicators of CF and other factors must meet minimum requirements.